Is GCTK research on Rallies investment advice?

No. Rallies provides research, data, and educational context for GCTK. It does not provide personalized investment advice.

GCTK (GlucoTrack, Inc. Common Stock) Stock Analysis - Financials

GlucoTrack, Inc. Common Stock (GCTK) is a publicly traded Healthcare sector company. As of July 8, 2026, GCTK trades at $0.37 with a market cap of $1.99M and a P/E ratio of 0.01. GCTK moved +12.14% today. Year to date, GCTK is -89.57%; over the trailing twelve months it is -94.35%. Its 52-week range spans $0.29 to $468.00. Rallies surfaces GCTK's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What are GCTK's key financials?

GCTK financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. GCTK recently traded at $0.37. Market cap is $1.99M. P/E ratio is 0.01. Revenue is $0.

GCTK Key Metrics

Key financial metrics for GCTK
Metric	Value
Price	$0.37
Market Cap	$1.99M
P/E Ratio	0.01
EPS	$31.22
Dividend Yield	0.00%
52-Week High	$468.00
52-Week Low	$0.29
Volume	2.90M
Avg Volume	0
Revenue (TTM)	$0
Net Income	$-19.39M
Gross Margin	0.00%

GCTK Analyst Consensus

GCTK analyst coverage data. Average price target: $0.00.

Common questions about GCTK

What are GCTK's key financials?: GCTK financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. GCTK recently traded at $0.37. Market cap is $1.99M. P/E ratio is 0.01. Revenue is $0.
Is GCTK research on Rallies investment advice?: No. Rallies provides research, data, and educational context for GCTK. It does not provide personalized investment advice.